Pitavastatin-d4 sodium

• CAT Number: S000047
• Molecular Formula: C25H19D4FNNaO4
• Molecular Weight: 447.47
• Purity: ≥95%
• Target: Metabolic Enzyme/Protease
• IUPAC Name: sodium;(E,3R,5S)-7-[4-(4-fluorophenyl)-2-(2,2,3,3-tetradeuteriocyclopropyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate
• InChI: InChI=1S/C25H24FNO4.Na/c26-17-9-7-15(8-10-17)24-20-3-1-2-4-22(20)27-25(16-5-6-16)21(24)12-11-18(28)13-19(29)14-23(30)31;/h1-4,7-12,16,18-19,28-29H,5-6,13-14H2,(H,30,31);/q;+1/p-1/b12-11+;/t18-,19-;/m1./s1/i5D2,6D2
• InChIKey: NBDQGOCGYHMDSJ-RGWFYQDJSA-M
• SMILES: [2H]C1(C(C1([2H])[2H])C2=NC3=CC=CC=C3C(=C2/C=C/[C@H](C[C@H](CC(=O)[O-])O)O)C4=CC=C(C=C4)F)[2H].[Na+]

Pitavastatin-d4 Sodium is a high-purity deuterated compound used in advanced pharmaceutical research. This isotopically labeled version of Pitavastatin is essential for studies involving HMG-CoA reductase inhibitors, lipid-lowering agents, pharmacokinetics, and metabolic pathways. Featuring four deuterium atoms, it ensures precise and reliable analytical results. The sodium salt form enhances solubility and stability, making it suitable for various experimental setups. Ideal for cardiovascular research and drug development, Pitavastatin-d4 Sodium integrates seamlessly into existing protocols, offering a robust and cost-effective solution for high-precision scientific investigations.